Clinical Trials

Postoperative analgesia for infusion found to be effective, company announces

Published in Medical Letter on the CDC and FDA, August 21st, 2005

Xsira Pharmaceuticals, Inc. announced that its investigational new drug application (IND) for intravenous was filed on June 3, 2005, with the U.S. Food and Drug Administration (FDA) and is now active.

Under the IND, Xsira intends to develop adenosine as an intraoperative infusion to reduce postoperative pain following surgery. Patient enrollment into a phase 2, multicenter clinical trial is expected to commence in the fall. Published clinical studies of adenosine in the surgical setting have been conducted under various physician-sponsored investigations in over 300 patients in the U.S. and abroad.

Pain in the immediate postoperative period remains a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2005-08-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry